Genomic analysis of early adenocarcinoma of the esophagus or gastroesophageal junction: Tumor progression is associated with alteration of 1q and 8p sequences

Genes Chromosomes and Cancer

Volumn 45, Issue 5, 2006, Pages 516-525

  Van Dekken, Herman ^a,c   Wink, Josiane C ^a   Vissers, Kees J ^a   Van Marion, Ronald ^a   Koppert, Linetta B ^a   Tilanus, Hugo W ^a   Siersema, Peter D ^a   Tanke, Hans J ^b   Szuhai, Karoly ^b   Hop, Wim C J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CHROMOSOME 11Q; CHROMOSOME 15Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 1Q; CHROMOSOME 20P; CHROMOSOME 20Q; CHROMOSOME 4P; CHROMOSOME 5Q; CHROMOSOME 6P; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME ARM; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; EARLY CANCER; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE METASTASIS; MALE; MOLECULAR CLONING; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 8; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION;

BACTERIA (MICROORGANISMS);

EID: 33645821655     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20315     Document Type: Article

References (49)

1. Andersson A, Eden P, Lindgren D, Nilsson J, Lassen C, Heldrup J, Fontes M, Borg A, Mitelman F, Johansson B, Hoglund M, Fioretos T. 2005. Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations. Leukemia 19:1042-1050.
2. Barrett MT, Galipeau PC, Sanchez CA, Emond MJ, Reid BJ. 1996. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 12:1873-1878.
3. Barrett MT, Sanchez CA, Prevo LJ, Wong BA, Galipeau PC, Paulson TG, Rabinovitch PS, Reid BJ. 1999. Evolution of neoplastic cell lineages in Barrett's esophagus. Nat Genet 22:106-109.
4. Bruno MJ. 2003. Magnification endoscopy, high resolution endoscopy, and chromoscopy; towards a better optical diagnosis. Gut 52 (Suppl 4):iv7-iv11.
5. Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, ten Kate FJ, van Lanschot JJ. 2004. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 60:703-710.
6. Dolan K, Garde J, Gosney J, Sissons M, Wright T, Kingsnorth AN, Walker SJ, Sutton R, Meltzer SJ, Field JK. 1998. Allelotype analysis of oesophageal adenocarcmoma: Loss of heterozygosity occurs at multiple sites. Br J Cancer 78:950-957.
7. Ell C, May A, Gossner L, Pech O, Gunter E, Mayer G, Henrich R, Vieth M, Muller H, Seitz G, Stolte M. 2000. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118:670-677.
8. Falk GW. 2002. Barrett's esophagus. Gastroenterology 122:1569-1591.
9. Froelicher P, Miller G. 1986. The European experience with esophageal cancer limited to the mucosa and submucosa. Gastrointest Endosc 32:88-90.
10. Galipeau PC, Prevo LJ, Sanchez CA, Longton GM, Reid BJ. 1999. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst 91:2087-2095.
11. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL, Russell SE. 1998. Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence. Genes Chromosomes Cancer 21:49-60.
12. Gonzalez MV, Artimez ML, Rodrigo L, Lopez-Larrea C, Menendez MJ, Alvarez V, Perez R, Fresno MF, Perez MJ, Sampedro A, Coto E. 1997. Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. J Clin Pathol 50:212-217.
13. Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE, Smith J, Vetrie D, Gorman P, Tomlinson IP, Carter NP. 2003. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36:361-374.
14. Fukushima N, Sato N, Prasad N, Leach SD, Hruban RH, Goggins M. 2004. Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays. Oncogene 23:9042-9051.
15. Gratias S, Schuler A, Hitpass LK, Stephan H, Rieder H, Schneider S, Horsthemke B, Lohmann DR. 2005. Genomic gains on chromosome 1q in retinoblastoma: consequences on gene expression and association with clinical manifestation. Int J Cancer 116:555-563.
16. Hage M, Siersema PD, van Dekken H, Steyerberg EW, Haringsma J, van de Vrie W, Grool TE, van Veen RLP, Sterenborg HCJM, Kuipers EJ. 2004. 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's esophagus: a randomized trial. Gut 53:785-790.
17. Han Q, Leng J, Bian D, Mahanivong C, Carpenter KA, Pan ZK, Han J, Huang S. 2002. Rac1-MKK3-p38-MAPKAPK2 pathway-promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells. J Biol Chem 277:48379-48385.
18. Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. 1995. Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer 76:178-186.
19. Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF, ten Kate FJ, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJ. 2002. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662-1669.
20. Japanese Society of Esophageal Diseases. 1999. Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. 9th ed. Tokyo: Kanehara.
21. Jiang JK, Chen YJ, Lin CH, Yu IT, Lin JK. 2005. Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases: an analysis by comparative genomic hybridization. Genes Chromosomes Cancer 43:25-36.
22. Kim TY, Jong HS, Song SH, Dimtchev A, Jeong SJ, Lee JW, Kim TY, Kim NK, Jung M, Bang YJ. 2003. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Oncogene 22:3943-3951.
23. Knijnenburg J, Szuhai K, Giltay J, Molenaar L, Sloos W, Foot M, Tanke HJ, Rosenberg C. 2005. Insights from genomic microarrays into structural chromosome rearrangements. Am J Med Genet A 132:36-40.
24. Lee HW, Lee SS, Lee SJ, Um HD. 2003. Bcl-w is expressed in a majority of infiltrative gastric adenocarcinomas and suppresses the cancer cell death by blocking stress-activated protein kinase/c-Jun NH2-terminal kinase activation. Cancer Res 63:1093-1100.
25. Menke-Pluymers MB, Schoute NW, Mulder AH, Hop WC, van Blankenstein M, Tilanus HW. 1992. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 33:1454-1458.
26. Miller CT, Moy JR, Lin L, Schipper M, Normolle D, Brenner DE, Iannettoni MD, Orringer MB, Beer DG. 2003. Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia. Clin Cancer Res 9:4819-4825.
27. Paris PL, Andaya A, Fridlyand J, Jain AN, Weinberg V, Kowbel D, Brebner JH, Simko J, Watson JEV, Volik S, Albertson DG, Pinkel D, Alers JC, van der Kwast ThH, Vissers KJ, Schroder FH, Wildhagen MF, Febbo PG, Chinnaiyan AM, Pienta KJ, Carroll PR, Rubin MA, Collins C, van Dekken H. 2004. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet 13:1303-1313.
28. Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC. 1992. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg 54:199-204.
29. Qin LX, Tang ZY, Sham JS, Ma ZC, Ye SL, Zhou XD, Wu ZQ, Trent JM, Guan XY. 1999. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res 59:5662-5665.
30. Rice TW, Blackstone EH, Goldblum JR, DeCamp MM, Murthy SC, Falk GW, Ormsby AH, Rybicki LA, Richter JE, Adelstein BA. 2001. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 122:1077-1090.
31. Riegman PHJ, Vissers KJ, Alers JC, Geelen E, Hop WCJ, Tilanus HW, van Dekken H. 2001. Genomic alterations in malignant transformation of Barrett's esophagus. Cancer Res 61:3164-3170.
32. Rosenberg C, Geelen E, IJszenga MJ, Pearson P, Tanke HJ, Dinjens WN, van Dekken H. 2002. Spectrum of genetic changes in gastro-esophageal cancer cell lines determined by an integrated molecular cytogenetic approach. Cancer Genet Cytogenet 135:35-41.
33. Sobin LH, Wittekind C. 2002. TNM classification of malignant tumours: International Union Against Cancer. 6th ed. New York: Wiley-Liss. p 60-68.
34. Tai AL, Yan WS, Fang Y, Xie D, Sham JS, Guan XY. 2004. Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between 1q amplification and tumor recurrence. Cancer 100:1918-1927.
35. Takubo K, Sasajima K, Yamashita K, Tanaka Y, Fujita K. 1991. Double muscularis mucosae in Barrett's esophagus. Hum Pathol 22:1158-1161.
36. Tsuji S, Hosotani R, Yonehara S, Masui T, Tulachan SS, Nakajima S, Kobayashi H, Koizumi M, Toyoda E, Ito D, Kami K, Mori T, Fujimoto K, Doi R, Imamura M. 2003. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma. Int J Cancer 106:17-25.
37. Van Dekken H, Geelen E, Dinjens WNM, Wijnhoven BPL, Tilanus HW, Tanke HJ, Rosenberg C. 1999. Comparative genomic hybridization of cancer of the gastro-esophageal junction: Deletion of 14q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas. Cancer Res 59:748-752.
38. Van Dekken H, Alers JC, Riegman PHJ, Rosenberg C, Tilanus HW, Vissers K. 2001. Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions. Am J Pathol 158:1961-1967.
39. Walch AK, Zitzelsberger HF, Bruch J, Keller G, Angermeier D, Aubele MM, Mueller J, Stein H, Braselmann H, Siewert JR, Höfler H, Werner M. 2000. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia- carcinoma sequence. Am J Pathol 156:555-566.
40. Westerterp M, Koppert LB, Buskens CJ, Tilanus HW, ten Kate FJW, Bergman JJHGM, Siersema PD, van Dekken H, van Lanschot JJB. 2005. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 446:497-504.
41. Wild PJ, Herr A, Wissmann C, Stoehr R, Rosenthal A, Zaak D, Simon R, Knuechel R, Pilarsky C, Hartmann A. 2005. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder. Clin Cancer Res 11:4415-4429.
42. Wong CM, Lee JM, Ching YP, Jin DY, Ng IO. 2003. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res 63:7646-7651.
43. Wu TT, Watanabe T, Heitmiller R, Zahurak M, Forastiere AA, Hamilton SR. 1998. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction. Am J Pathol 153:287-294.
44. Yang SH, Seo MY, Jeong HJ, Jeung HC, Shin J, Kim SC, Noh SH, Chung HC, Rha SY. 2005. Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients. Clin Cancer Res 11:612-620.
45. Yuan BZ, Jefferson AM, Baldwin KT, Thorgeirsson SS, Popescu NC, Reynolds SH. 2004. DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene 23:1405-1411.
46. Zaharieva BM, Simon R, Diener PA. Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Hering F, Schonenberger A, Flury R, Jager P, Fehr JL, Mihatsch MJ, Gasser T, Sauter G, Toncheva DI. 2003. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol 201:603-608.
47. Zaninotto G, Parenti AR, Ruol A, Costamini M, Merigliano S, Ancona E. 2000. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br J Surg 87:1102-1105.
48. Zhu Y, Zhong X, Zheng S, Ge Z, Du Q, Zhang S. 2005. Transformation of immortalized colorectal crypt cells by microcystin involving constitutive activation of Akt and MAPK cascade. Carcinogenesis 26:1207-1214.
49. Zhuang Z, Vortmeyer AO, Mark EJ, Odze R, Emmert-Buck MR, Merino MJ, Moon H, Liotta LA, Duray PH. 1996. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res 56:1961-1964.